Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.000
+0.010 (1.01%)
Jun 20, 2025, 4:00 PM - Market closed
Dyadic International Employees
Dyadic International had 6 employees as of December 31, 2024. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
$592,391
Profits / Employee
-$971,190
Market Cap
30.09M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
DYAI News
- 20 days ago - Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications - GlobeNewsWire
- 5 weeks ago - Dyadic International, Inc. (DYAI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - GlobeNewsWire
- 2 months ago - Dyadic to Present at World Vaccine Congress | Washington - GlobeNewsWire
- 3 months ago - Dyadic International, Inc. (DYAI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Dyadic Reports 2024 Year-End Financial Results and Business Updates - GlobeNewsWire
- 3 months ago - Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025 - GlobeNewsWire
- 3 months ago - Dyadic to Attend Multiple Industry Events in March - GlobeNewsWire